Cargando…

Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease

Sarcopenia and nonalcoholic fatty liver disease (NAFLD) are associated with subclinical atherosclerosis. We aimed to investigate the association between low skeletal muscle mass (LSMM) and subclinical atherosclerosis in patients with NAFLD. A total of 683 patients with ultrasound-confirmed NAFLD who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Min-Kyu, Park, Jung-Gil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150334/ https://www.ncbi.nlm.nih.gov/pubmed/34068776 http://dx.doi.org/10.3390/diagnostics11050854

Ejemplares similares

Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis
por: Kang, Min Kyoung, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease in Hispanic Youth With Dysglycemia: Risk for Subclinical Atherosclerosis?
por: Bacha, Fida, et al.
Publicado: (2017)

Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men
por: Lee, Jung Eun, et al.
Publicado: (2018)

The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass
por: Choe, Eun Kyung, et al.
Publicado: (2018)

Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients
por: Bae, Ye Seul, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths
por: Pacifico, Lucia, et al.
Publicado: (2020)

The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
por: Moon, Jun Sung, et al.
Publicado: (2013)

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019)

Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
por: Byeon, Jun-Hyeon, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta‐analysis
por: Zhou, Yao‐Yao, et al.
Publicado: (2018)

Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
por: Jo, Ik Hyun, et al.
Publicado: (2023)

Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study
por: Lee, Min Jung, et al.
Publicado: (2019)

Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease
por: Altajar, Sarah, et al.
Publicado: (2020)

Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease
por: Matsumoto, Yoshinari, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease as an independent risk factor for carotid atherosclerosis
por: Rasool, Abid, et al.
Publicado: (2017)

Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease
por: Taylan, Gökay, et al.
Publicado: (2022)

Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Cai, Changzhou, et al.
Publicado: (2019)

Novel predictors of early atherosclerosis in nonalcoholic fatty liver disease
por: Abdulaziz, Badawy Abdulkhalik, et al.
Publicado: (2023)

Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old
por: Zheng, Jilin, et al.
Publicado: (2018)

Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease
por: Oğuz, Didem, et al.
Publicado: (2016)

Subclinical thyroid dysfunction and risk of carotid atherosclerosis
por: Kim, Hosu, et al.
Publicado: (2017)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver
por: Kang, Min-Kyu, et al.
Publicado: (2021)

Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
por: Xu, Xin, et al.
Publicado: (2015)

Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
por: Nam, Ga Eun, et al.
Publicado: (2018)

Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease
por: Hossain, Israt Ara, et al.
Publicado: (2016)

Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients
por: Liu, Lu, et al.
Publicado: (2017)

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE(−/−)FXR(−/−) Mice
por: Lee, Yenna, et al.
Publicado: (2021)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Association of serum creatinine-to-cystatin C ratio with skeletal muscle mass and strength in nonalcoholic fatty liver disease in the Iwaki Health Promotion Project
por: Mikami, Kenichiro, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

SAT-LB015 Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver in Children with Overweight and Obesity
por: Nichols, Presley, et al.
Publicado: (2019)

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2021)

Is subclinical atherosclerosis associated with visceral fat and fatty liver in adolescents with type 1 diabetes?
por: Atwa, Hoda, et al.
Publicado: (2018)

Verification of the Nutritional and Dietary Factors Associated with Skeletal Muscle Index in Japanese Patients with Nonalcoholic Fatty Liver Disease
por: Himoto, Takashi, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution
por: Alferink, Louise Johanna Maria, et al.
Publicado: (2019)

Comparison of carotid intima–media thickness and coronary artery calcium score for estimating subclinical atherosclerosis in patients with fatty liver disease
por: Hyun-Jin, Kim, et al.
Publicado: (2018)

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis
por: Bessho, Rieko, et al.
Publicado: (2022)

Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs
por: Yamada, Sohsuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_odckkjtnce1rl4r7dmsfripin1